换一批Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
第一作者：
Angela Mc,Rose
第一单位：
Epiconcept, Paris, France.
作者：
Angela Mc,Rose [1]
;
Nathalie,Nicolay [2]
;
Virginia,Sandonis Martín [3]
;
Clara,Mazagatos [4]
;
Goranka,Petrović [5]
;
Joaquin,Baruch [6]
;
Sarah,Denayer [7]
;
Lucie,Seyler [8]
;
Lisa,Domegan [9]
;
Odile,Launay [10]
;
Ausenda,Machado [11]
;
Cristina,Burgui [12]
;
Roberta,Vaikutyte [13]
;
F Annabel,Niessen [14]
;
Isabela I,Loghin [15]
;
Petr,Husa [16]
;
Nassera,Aouali [17]
;
George,Panagiotakopoulos [18]
;
Kristin,Tolksdorf [19]
;
Judit Krisztina,Horváth [20]
;
Jennifer,Howard [1]
;
Francisco,Pozo [3]
;
Virtudes,Gallardo [21]
;
Diana,Nonković [22]
;
Aušra,Džiugytė [6]
;
Nathalie,Bossuyt [7]
;
Thomas,Demuyser [8]
;
Róisín,Duffy [9]
;
Liem Binh,Luong Nguyen [23]
;
Irina,Kislaya [11]
;
Iván,Martínez-Baz [12]
;
Giedre,Gefenaite [24]
;
Mirjam J,Knol [14]
;
Corneliu,Popescu [25]
;
Lenka,Součková [26]
;
Marc,Simon [27]
;
Stella,Michelaki [18]
;
Janine,Reiche [19]
;
Annamária,Ferenczi [20]
;
Concepción,Delgado-Sanz [4]
;
Zvjezdana,Lovrić Makarić [5]
;
John Paul,Cauchi [6]
;
Cyril,Barbezange [7]
;
Els,Van Nedervelde [8]
;
Joan,O'Donnell [9]
;
Christine,Durier [28]
;
Raquel,Guiomar [11]
;
Jesús,Castilla [12]
;
Indrė,Jonikaite [13]
;
Patricia Cjl,Bruijning-Verhagen [29]
;
Mihaela,Lazar [30]
;
Regina,Demlová [31]
;
Gil,Wirtz [27]
;
Marina,Amerali [18]
;
Ralf,Dürrwald [19]
;
Mihály Pál,Kunstár [20]
;
Esther,Kissling [1]
;
Sabrina,Bacci [2]
;
Marta,Valenciano [1]
;
I-MOVE-COVID-19 hospital study team [32]
;
VEBIS hospital study team [32]
;
Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above)
作者单位：
Epiconcept, Paris, France.
[1]
European Centre for Disease Prevention and Control, Stockholm, Sweden.
[2]
National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
[3]
National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.;Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
[4]
Croatian Institute of Public Health, Zagreb, Croatia.
[5]
IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta.
[6]
Sciensano, Brussels, Belgium.
[7]
Universitair Ziekenhuis Brussel, Brussels, Belgium.
[8]
Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
[9]
Inserm, CIC Cochin-Pasteur, Paris, France.;AP-HP, Hôpital Cochin, Paris, France.;Faculty of Medicine, University of Paris City, Paris, France.
[10]
National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
[11]
Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.;Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
[12]
Lithuanian University of Health Sciences, Kaunas, Lithuania.
[13]
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
[14]
St. Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.;Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
[15]
Faculty of Medicine, Masaryk University, Brno, Czechia.;University Hospital Brno, Brno, Czechia.
[16]
Luxembourg Institute of Health, Luxembourg.
[17]
National Public Health Organisation (EODY), Athens, Greece.
[18]
Robert Koch Institute, Berlin, Germany.
[19]
National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.
[20]
Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Spain.
[21]
Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia.
[22]
AP-HP, Hôpital Cochin, Paris, France.
[23]
Faculty of Medicine, Lund University, Lund, Sweden.;Lithuanian University of Health Sciences, Kaunas, Lithuania.
[24]
Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.;Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
[25]
University Hospital Brno, Brno, Czechia.
[26]
Centre Hospitalier de Luxembourg, Luxembourg.
[27]
Inserm, US19, Villejuif, Paris, France.
[28]
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.;Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
[29]
"Cantacuzino" National Military Medical Institute for Research-Development, Bucharest, Romania.
[30]
Faculty of Medicine, Masaryk University, Brno, Czechia.
[31]
The members of these groups are listed under Collaborators.
[32]
DOI
10.2807/1560-7917.ES.2023.28.47.2300187
PMID
37997665
发布时间
2024-10-14
- 浏览0
Euro surveillance
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
